Argenx Se Stock News

A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for the year-to-date peri

argenx SE (NASDAQ:ARGX) Stock analysts at Piper Sandler lowered their FY2021 earnings estimates for shares of argenx in a report issued on Monday, November 29th. Piper Sandler analyst E. Tenthoff now anticipates that the company will post earnings per share of ($8.54) for the year, down from their prior forecast of ($8.13). Piper Sandler []

Wall Street brokerages predict that argenx SE (NASDAQ:ARGX) will announce $10.23 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for argenxs earnings, with the lowest sales estimate coming in at $5.70 million and the highest estimate coming in at $14.00 million. argenx posted sales of $7.59 []

Analysts predict that argenx SE (NASDAQ:ARGX) will announce earnings per share (EPS) of ($5.05) for the current quarter, according to Zacks. Four analysts have made estimates for argenxs earnings, with estimates ranging from ($6.71) to ($4.08). argenx posted earnings per share of ($4.20) in the same quarter last year, which would indicate a negative year-over-year []

Cubist Systematic Strategies LLC increased its position in shares of argenx SE (NASDAQ:ARGX) by 141.3% in the second quarter, Holdings Channel reports. The institutional investor owned 1,349 shares of the companys stock after buying an additional 790 shares during the period. Cubist Systematic Strategies LLCs holdings in argenx were worth $406,000 as of its most []

Wall Street brokerages expect argenx SE (NASDAQ:ARGX) to announce $10.23 million in sales for the current quarter, according to Zacks. Four analysts have issued estimates for argenxs earnings. The lowest sales estimate is $5.70 million and the highest is $14.00 million. argenx posted sales of $7.59 million in the same quarter last year, which suggests []

State Street Corp reduced its holdings in argenx SE (NASDAQ:ARGX) by 8.9% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 50,865 shares of the companys stock after selling 4,968 shares during the period. State Street Corps holdings in argenx were worth $15,314,000 as of its most recent filing with the Securities & Exchange []

Baron funds took big stakes in Nvidia, Sea, Shopify and other companies in the third quarter.

Related Stocks: AMRN , KYMR , LXRX , CRNX , RAIN , VSTM , GLPG , AADI , TYRA , PNT , ALPN , ELEV , MRUS , RACA , FBRX , IMVT , CNTA ,

Related Stocks: ARGX , AAPL , ALT , EQ , VIR , BABA , IMPL , MRVL , AZN , LIT , TBT , WBA , KIN , ALXN , JNJ , IBM , KSS , KWEB ,

November 10, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and canc

argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q3 2021 Results - Earnings Call Transcript

October 21 , 202 1 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and can

Breda, the Netherlands – October 8 , 2021 – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and c